Publications by authors named "Kikiowo Babatomiwa"

The rapid occurrence of gonococcal resistance to all classes of antibiotics could lead to untreatable gonorrhea. Thus, development of novel anti-Neisseria gonorrhoeae drugs is urgently needed. Neisseria gonorrhoeae FA1090 is the most used in gonococcal infection mouse models because of its natural resistance to streptomycin.

View Article and Find Full Text PDF

Dipeptidyl peptidase-4 (DPP4) inhibitors are a potent therapeutic treatment for type 2 diabetes mellitus (T2DM). There is a family of compounds used as DPP4 inhibitors (DPP4Is) called gliptins. They bind tightly to DPP4 to form an inactive protein-ligand complex.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetes mellitus (DM) is a serious metabolic disorder leading to high blood sugar levels and significant organ damage, with Type 2 DM (T2D) being the most common form characterized by insulin resistance and pancreatic dysfunction.
  • Current treatments like acarbose can effectively lower blood sugar but may have severe side effects, indicating a need for safer alternatives.
  • Research into compounds like quercetin and ombuin using molecular dynamics simulations shows promise as potential anti-DM drugs with better properties and fewer side effects compared to existing treatments.
View Article and Find Full Text PDF
Article Synopsis
  • The study explored how quercetin protects against immune suppression caused by cyclophosphamide (CYP) in male Wister rats, focusing on oxidative and inflammatory stress impacts.
  • Quercetin, when administered alongside CYP, helped reduce oxidative stress and inflammation in brain regions by boosting antioxidant enzyme activity and lowering harmful markers like interleukin-6 and interferon-γ.
  • Behavioral tests showed that quercetin significantly improved depressive-like behaviors in rats treated with CYP, suggesting its potential as a protective agent against stress-induced mental health issues.
View Article and Find Full Text PDF

Background: Breast Cancer (BC), a common fatal disease and the deadliest cancer next to lung cancer, is characterized by an abnormal growth of cells in the tissues of the breast. BC chemotherapy is marked by targeting the activities of some receptors such as Estrogen Receptor alpha (ER-α). At present, one of the most commonly used and approved marketed therapeutic drugs for BC is tamoxifen.

View Article and Find Full Text PDF

Type II Diabetes Mellitus (DM) is caused by insulin resistance in peripheral tissue and impaired insulin secretion through a dysfunction of the pancreatic β-cell. Acarbose is an anti-DM drug, it is effective but its continuous use may lead to undesirable side effects. Hence, the development of novel drugs from natural source that have both anti-diabetic and anti-oxidant activities, with little or no side effect during long-term use is of great importance.

View Article and Find Full Text PDF

Gout is a type of painful inflammation initiated by the interactions between monosodium urate crystals and connective tissue. Xanthine oxidase (XO) catalyzes the oxidation of hypoxanthine to xanthine, then to uric acid. The primary treatments for gout include XO inhibitors.

View Article and Find Full Text PDF

Background: In a bid to come up with effective compounds as inhibitors for antimalarial treatment, we built a library of 2,000 traditional Chinese medicine(TCM)-derived compounds retrieved from TCM Database@Taiwan.

Methods: The active sites of both the wild type and mutant Plasmodium falciparum dihydrofolatereductase (pfDHFR) were explored using computational tools. pfDHFR, one of the prime drug targets in the prevention of malaria infection induced by the female anopheles mosquito has continued to offer resistance to drugs (antifolates) due to mutation in some of the key amino acid residues crucial for its inhibition.

View Article and Find Full Text PDF

Background: BACE-1 is an aspartate protease that is responsible for the proteolysis of amyloid precursor proteins (APP) into beta-amyloid (Aβ), a neurotoxic peptide in patients with Alzheimer's disease (AD). As such, BACE-1 is a prime pharmacological target in the control of Aβ in the brain and its inhibition will be a sound approach in AD therapy.

Methods: The computational pipeline which comprised molecular docking (MD), Quantitative Structure Activity Relationship (QSAR) modelling and Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) studies enabled the prediction of molecular interaction and relative inhibitory potentials of the hit compound.

View Article and Find Full Text PDF